Comera Life Sciences Holdings Inc. logo

Comera Life Sciences (CMRA) stock

CMRA · Comera Life Sciences Holdings Inc. · NASDAQ

Website

What is the latest news on CMRA stock?

SECago
SEC Form EFFECT filed by Comera Life Sciences Holdings Inc.

EFFECT - Comera Life Sciences Holdings, Inc. (0001907685) (Filer)

All CMRA news

When does Comera Life Sciences report earnings?

The latest Comera Life Sciences earnings release came out on Nov 9, 2023: Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights. Before that, Comera Life Sciences reported on Aug 10, 2023 and May 11, 2023.

CMRA earnings history

Latest news

25 items

Comera Life Sciences Holdings Inc. (CMRA) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for CMRA in the last 30 days. The most recent was published Feb 28, 2024.

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

CMRA FAQ

5 questions
  • What does Comera Life Sciences Holdings Inc. do?
    Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is...
  • Where does CMRA stock trade?
    Comera Life Sciences Holdings Inc. (CMRA) is listed on NASDAQ.
  • What sector and industry is CMRA in?
    Comera Life Sciences Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • What companies are similar to CMRA?
    Notable peers in the same industry include EXEL (Exelixis Inc.), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.), MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.). Compare CMRA side-by-side with any of them on Quantisnow.
  • How can I track CMRA on Quantisnow?
    Quantisnow aggregates Comera Life Sciences Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CMRA to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change